We are live on ! Find out more
VIVO

Meridian Bioscience Inc

Delisted

VIVO was delisted on the 30th of January, 2023.

177 hedge funds and large institutions have $592M invested in Meridian Bioscience Inc in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 62 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

684% more call options, than puts

Call options by funds: $1.31M | Put options by funds: $167K

13% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 16

0% more funds holding

Funds holding: 177177 (0)

3% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 62

4% less capital invested

Capital invested by funds: $615M → $592M (-$22.8M)

Holders
177
Holders Change
Holders Change %
0%
% of All Funds
4.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
60
Reduced
62
Closed
16
Calls
$1.31M
Puts
$167K
Net Calls
+$1.14M
Net Calls Change
-$704K
Name Holding Trade Value Shares
Change
Change in
Stake
Thrivent Financial for Lutherans
101
Thrivent Financial for Lutherans
Minnesota
$440K +$7.54K +486 +2%
Public Sector Pension Investment Board (PSP Investments)
102
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$435K +$37.4K +2,409 +9%
CCMINC
103
Cardinal Capital Management Inc (North Carolina)
North Carolina
$430K -$620 -40 -0.1%
Manulife (Manufacturers Life Insurance)
104
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$424K -$54.8K -3,533 -11%
TPSF
105
Texas Permanent School Fund
Texas
$397K -$10.1K -654 -2%
State of Tennessee, Department of Treasury
106
State of Tennessee, Department of Treasury
Tennessee
$392K -$47.4K -3,056 -10%
CIC
107
Cornercap Investment Counsel
Georgia
$377K -$43.9K -2,832 -10%
PI
108
PineBridge Investments
New York
$371K +$134K +8,664 +53%
Nisa Investment Advisors
109
Nisa Investment Advisors
Missouri
$370K +$20.2K +1,300 +6%
VAM
110
Verity Asset Management
North Carolina
$366K -$43.3K -2,793 -10%
GAM
111
Gotham Asset Management
New York
$362K -$32.7K -2,107 -8%
UBS AM
112
UBS AM
Illinois
$346K
MC
113
Menta Capital
California
$338K +$372 +24 +0.1%
MIM
114
MetLife Investment Management
New Jersey
$336K
LPL Financial
115
LPL Financial
California
$318K -$7.58K -489 -2%
UBS Group
116
UBS Group
Switzerland
$287K +$90.5K +5,837 +44%
SOADOR
117
State of Alaska Department of Revenue
Alaska
$285K +$85.4K +5,505 +40%
LSERS
118
Louisiana State Employees Retirement System
Louisiana
$279K -$4.65K -300 -2%
VOYA Investment Management
119
VOYA Investment Management
Georgia
$275K
JMPWA
120
JP Morgan Private Wealth Advisors
California
$275K +$38.7K +2,498 +16%
FIM
121
Freedom Investment Management
Connecticut
$268K -$8.7K -561 -3%
TRSOTSOK
122
Teachers Retirement System of the State of Kentucky
Kentucky
$242K
HIMCH
123
Hartford Investment Management Co (HIMCO)
Connecticut
$235K -$13.1K -844 -5%
Public Employees Retirement Association of Colorado
124
Public Employees Retirement Association of Colorado
Colorado
$229K
JIC
125
Johnson Investment Counsel
Ohio
$222K

VIVO Hedge Fund Activity: Q3 2018 in Review

177 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2018, worth a combined $592M — down 3.7% from $615M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new VIVO positions and 16 closed out — a net gain of 2 holders — while 60 added to existing stakes and 62 trimmed.

The largest buyer was BlackRock, adding an estimated $5.08M. The largest seller was Millennium Management, cutting an estimated $2.6M.

  • 177 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $592M of Meridian Bioscience Inc stock for Q3 2018, down 3.7% quarter-over-quarter.
  • 18 funds opened new Meridian Bioscience Inc positions in Q3 2018 and 16 closed out, a net change of +2 holders.
  • The largest Meridian Bioscience Inc buyer in Q3 2018 was BlackRock, an estimated $5.08M added.
  • The largest Meridian Bioscience Inc seller in Q3 2018 was Millennium Management, an estimated $2.6M sold.

Based on aggregated 13F filings for Q3 2018.